Retrophin

From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives
From ‘Rain Man’ to ‘Pied Piper,’ Shkreli's actions confounded Retrophin executives
Fierce Pharma
Martin Shkreli
fraud
Retrophin
Flag link:
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Endpoints
Martin Shkreli
biotech
Retrophin
fraud
Flag link:
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Martin Shkreli’s former biotech company Retrophin is leaving Cambridge
Bizjournals.com
Retrophin
Cambridge
Martin Shkreli
Flag link:
Martin Shkreli in court as securities fraud case moves closer to trial
Martin Shkreli in court as securities fraud case moves closer to trial
CNBC
Martin Shkreli
securities fraud
Retrophin
Flag link:
4 Key BioPharma Movers in the Past Week
4 Key BioPharma Movers in the Past Week
24/7 Wall St
Retrophin
Evoke Pharma
Celgene
Lexicon Pharmaceuticals
Flag link:
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
Retrophin (With Help From Martin Shkreli) Advances Drug for Rare Kidney Disease
TheStreet.com
Retrophin
Martin Shkreli
sparsentan
kidney disease
focal segmental glomerulosclerosis
Flag link:
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Bidness, ETC
Shire
Raptor Pharmaceuticals
M&A
Retrophin
Rare Diseases
Flag link:
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Bloomberg
Raptor Pharmaceuticals
Retrophin
Martin Shkreli
Flag link:
Facing new conspiracy charge, Martin Shkreli pleads not guilty
Facing new conspiracy charge, Martin Shkreli pleads not guilty
Marketwatch
Martin Shkreli
Retrophin
Flag link:
More charges against ex-pharmaceutical executive Shkreli
More charges against ex-pharmaceutical executive Shkreli
Yahoo/AP
Martin Shkreli
Retrophin
Flag link:
Even more charges are probably coming Martin Shkreli’s way
Even more charges are probably coming Martin Shkreli’s way
Marketwatch
Martin Shkreli
Retrophin
Flag link:
How Did Martin Shkreli Ever Become A Pharmaceutical CEO?
How Did Martin Shkreli Ever Become A Pharmaceutical CEO?
Forbes
Martin Shkreli
Pharma CEOs
Turing Pharmaceuticals
Retrophin
Flag link:
The company that took on Martin Shkreli's drug-price hikes has a new target
The company that took on Martin Shkreli's drug-price hikes has a new target
Yahoo/Business Insider
Martin Shkreli
Thiola
Retrophin
drug pricing
cystinuria
Imprimis Pharmaceuticals
Flag link:
One Reason We Think Biotech Has Bottomed
One Reason We Think Biotech Has Bottomed
Seeking Alpha
biotech
Allergan
AstraZeneca
Bristol-Myers Squibb
Celgene
Gilead Sciences
Horizon Pharma
Insys
Pfizer
Retrophin
Valeant Pharmaceuticals
ZS Pharma
Flag link:
Retrophin comes after Shkreli with a $65M suit and claims of flagrant mismanagement
Retrophin comes after Shkreli with a $65M suit and claims of flagrant mismanagement
Fierce Biotech
Retrophin
Martin Shkreli
Flag link:
Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday
Retrophin Turns Asklepion Voucher Into $245M Sanofi Payday
Xconomy
Retrophin
review vouchers
Sanofi
Asklepion Pharmaceuticals
FDA
Flag link:
Retrophin bags rare disease approval, FDA voucher in $75M deal
Retrophin bags rare disease approval, FDA voucher in $75M deal
Fierce Biotech
Retrophin
FDA
Cholbam
Flag link:
Shire’s Next Targets Could Be on This List: Real M&A
Shire’s Next Targets Could Be on This List: Real M&A
Bloomberg
Shire
M&A
PTC Therapeutics
SynaGeva BioPharma
Retrophin
Ultragenyx
Vertex Pharmaceuticals
Biomarin
Flag link:
Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals
Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals
Yahoo
Retrophin
cholic acid
Asklepion Pharmaceuticals
Flag link:
Ousted Retrophin CEO Sold Stock While Urging Investors to Buy
Ousted Retrophin CEO Sold Stock While Urging Investors to Buy
TheStreet.com
Retrophin
Martin Shkreli
Flag link: